Increasing legal costs may not be at the root of skyrocketing medical malpractice premiums, according to The New York Times (2/22/05).
Increasing legal costs may not be at the root of skyrocketing medical malpractice premiums, according to The New York Times (2/22/05). The Times reported that data from the National Practitioner Data Bank showed that the average medical malpractice payout fell from $268,605 in 2003 to $262,486 in 2004. During the same period, the number of payments made by insurers dropped from 18,996 to 17,696.
So what accounts for increasing malpractice premiums? Some suggest that declining investment earnings of insurance companies and a shift in competition in the industry are to blame. But with "headline-grabbing big awards" and data from the Physicians Insurers Association of America showing a rise in payments of more than $1 million to injured patients between 1993 and 2003, payouts for lawsuits may continue to "muddy the public picture," according to the report.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
2 Commerce Drive
Cranbury, NJ 08512